Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares COCH Q1 2026 Earnings EPS Beats Estimates Despite PreRevenue Status Stock Declines CVNA Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty FICO Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Scoring Business GPOR Q1 2026 Earnings EPS Slightly Misses Consensus Shares Edge Lower MHK Q1 2026 Earnings EPS Surprises on Cost Actions Shares Edge Higher